NCT01739309 2023-09-21Study of LY2835219 for Mantle Cell LymphomaEli Lilly and CompanyPhase 2 Completed28 enrolled 20 charts
NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT02014129 2020-08-24A Study of LY2835219 in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed12 enrolled 11 charts
NCT02745769 2019-03-05A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted AgentsEli Lilly and CompanyPhase 1 Completed23 enrolled